< Back to previous page
Project
Unravelling the mechanisms of drug resistance to proteasome inhibitors to optimize treatment in patients with multiple myeloma
The results of the project will enable better stratification of patients with multiple myeloma to allow optimal use of proteasome inhibators and to identify agents acting synergistically with proteasome inhibators.
Date:1 Jan 2019 → 31 Dec 2022
Keywords:cancer therapy
Disciplines:Cancer therapy